Plant Proteins

Ingredients and food and beverage products based on plant protein sources.

LUX TAKE:

Plant proteins will continue to be a key near-term opportunity for industry players. Clients should look to profit from the rising dominance of second-generation plant proteins like peas, chickpeas, canola, and oats, looking beyond soy. Innovation on the agriculture production side will help create plant protein ingredients richer in nutrients and protein content and with improved ease of ...

Data last updated on February 20, 2020

What's New

Lux Research analysts and the Lux Intelligence Engine have added the following recent plant proteins developments.

News Commentaries

Alpha Foods raises $28 million in Series A funding for its plant-based meat products, bringing its total to $35 million (February 14, 2020)

Israeli startup Yofix raises $2.5 million funding for plant-based dairy (February 14, 2020)

New Lux Content

Xampla (February 20, 2020)

NovaMeat (February 4, 2020)

New Patents

Computing...

New Investment Rounds

Computing...

Related companies	Parabel, Roquette, Oatly, TerViva, Beyond Meat, Calyxt, Kuli Kuli, Ambronite, Equinom, Hinoman, MycoTechnology, Impossible Foods, Prolupin, GreenOnyx, Triple A, Ripple Foods, Tofurky, 3f Bio, Good Dot, InnovoPro, ChickP, Nutriati, Nuritas, NotCo, NapiFeryn, Improved Nature, Plantible Foods, SavorEat, Redefine Meat, NovaMeat

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Interested in Learning More?

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978